US 11,673,918

Application 17/231,889 · Granted Jun 13, 2023

Method of manufacturing a pharmaceutical composition

Estimated expiration

August 10, 2038

11y 265d remaining

Confidence: high
High: no high-severity warning was raised, and any terminal disclaimer was resolved to the patents it references.
  • Could not fetch continuity data for application PCTEP2018071832: Resource not found (404)
Earliest effective filing
Aug 10, 2018
+ 20 years
Aug 10, 2038
PTA +0d
Aug 10, 2038
TD cap (US 10,981,955)
Aug 10, 2038
Final
Aug 10, 2038

This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included. Terminal disclaimers can affect PTA (In re Cellect, LLC).

Calculation details

Base term

Filing date
April 15, 2021
Earliest effective filing
August 10, 2018
Issue date
June 13, 2023
PTA
0 days
Base expiry (before PTA)
August 10, 2038

August 10, 2018 + 20 years = August 10, 2038

  • Continuation of application 16/637,499, filed Feb 7, 2020, issued as US 10,981,955
  • National stage entry of application PCTEP2018071832, filed Aug 10, 2018
  • National stage entry of application PCTEP2018071832, filed Aug 10, 2018

Terminal disclaimers

TD approved1 approved, 1 filed

TD caps expiration to August 10, 2038 (earliest expiring referenced patent: US 10,981,955)

  • US 10,981,955· Application 16/637,499Capping patent

    Method of manufacturing a pharmaceutical composition

    Filing date
    Feb 7, 2020
    Earliest effective filing
    Aug 10, 2018
    Issue date
    Apr 20, 2021
    PTA
    0 days
    Calculated expiration
    Aug 10, 2038

    National stage entry of PCTEP2018071832, filed Aug 10, 2018

    Aug 10, 2018 + 20y = Aug 10, 2038

  • US 11,673,918· Application 17/231,889(from application 17/231,889)

    Method of manufacturing a pharmaceutical composition

    Filing date
    Apr 15, 2021
    Earliest effective filing
    Aug 10, 2018
    Issue date
    Jun 13, 2023
    PTA
    0 days
    Calculated expiration
    Aug 10, 2038

    Continuation of 16/637,499, filed Feb 7, 2020, issued as US 10,981,955

    National stage entry of PCTEP2018071832, filed Aug 10, 2018

    National stage entry of PCTEP2018071832, filed Aug 10, 2018

    Aug 10, 2018 + 20y = Aug 10, 2038

Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated

You have the date. Your AI can have the file.

Application 17/231,889 · US 11,673,918

PatentReply compiles the prosecution history behind US 11,673,918: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.

One new published application a month is free. The first compile takes a few minutes.

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Permanent link

www.patentreply.ai/tools/patent-expiration/US11673918

Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.